Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eur Respir J ; 39(2): 297-304, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21719483

RESUMO

Respiratory virus infections play an important role in cystic fibrosis (CF) exacerbations, but underlying pathophysiological mechanisms are poorly understood. We aimed to assess whether an exaggerated inflammatory response of the airway epithelium on virus infection could explain the increased susceptibility of CF patients towards respiratory viruses. We used primary bronchial and nasal epithelial cells obtained from 24 healthy control subjects and 18 CF patients. IL-6, IL-8/CXCL8, IP-10/CXCL10, MCP-1/CCL2, RANTES/CCL5 and GRO-α/CXCL1 levels in supernatants and mRNA expression in cell lysates were measured before and after infection with rhinoviruses (RV-16 and RV-1B) and RSV. Cytotoxicity was assessed by lactate dehydrogenate assay and flow cytometry. All viruses induced strong cytokine release in both control and CF cells. The inflammatory response on virus infection was heterogeneous and depended on cell type and virus used, but was not increased in CF compared with control cells. On the contrary, there was a marked trend towards lower cytokine production associated with increased cell death in CF cells. An exaggerated inflammatory response to virus infection in bronchial epithelial cells does not explain the increased respiratory morbidity after virus infection in CF patients.


Assuntos
Fibrose Cística , Mucosa Nasal , Infecções por Picornaviridae , Mucosa Respiratória , Rhinovirus/imunologia , Brônquios/imunologia , Brônquios/patologia , Brônquios/virologia , Linhagem Celular , Fibrose Cística/imunologia , Fibrose Cística/patologia , Fibrose Cística/virologia , Citocinas/genética , Citocinas/imunologia , Expressão Gênica/imunologia , Humanos , Sistema Imunitário/imunologia , Sistema Imunitário/virologia , Mucosa Nasal/imunologia , Mucosa Nasal/patologia , Mucosa Nasal/virologia , Infecções por Picornaviridae/imunologia , Infecções por Picornaviridae/patologia , Infecções por Picornaviridae/virologia , Cultura Primária de Células , Mucosa Respiratória/imunologia , Mucosa Respiratória/patologia , Mucosa Respiratória/virologia , Rhinovirus/crescimento & desenvolvimento
2.
Eur Respir J ; 37(5): 1208-16, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21109556

RESUMO

Despite association with lung growth and long-term respiratory morbidity, there is a lack of normative lung function data for unsedated infants conforming to latest European Respiratory Society/American Thoracic Society standards. Lung function was measured using an ultrasonic flow meter in 342 unsedated, healthy, term-born infants at a mean ± sd age of 5.1 ± 0.8 weeks during natural sleep according to the latest standards. Tidal breathing flow-volume loops (TBFVL) and exhaled nitric oxide (eNO) measurements were obtained from 100 regular breaths. We aimed for three acceptable measurements for multiple-breath washout and 5-10 acceptable interruption resistance (R(int)) measurements. Acceptable measurements were obtained in ≤ 285 infants with high variability. Mean values were 7.48 mL·kg⁻¹ (95% limits of agreement 4.95-10.0 mL·kg⁻¹) for tidal volume, 14.3 ppb (2.6-26.1 ppb) for eNO, 23.9 mL·kg⁻¹ (16.0-31.8 mL·kg⁻¹) for functional residual capacity, 6.75 (5.63-7.87) for lung clearance index and 3.78 kPa·s·L⁻¹ (1.14-6.42 kPa·s·L⁻¹) for R(int). In males, TBFVL outcomes were associated with anthropometric parameters and in females, with maternal smoking during pregnancy, maternal asthma and Caesarean section. This large normative data set in unsedated infants offers reference values for future research and particularly for studies where sedation may put infants at risk. Furthermore, it highlights the impact of maternal and environmental risk factors on neonatal lung function.


Assuntos
Pulmão/fisiologia , Óxido Nítrico/normas , Testes Respiratórios , Estudos de Coortes , Feminino , Humanos , Lactente , Masculino , Estudos Prospectivos , Valores de Referência , Sono , Fumar/efeitos adversos
5.
Mucosal Immunol ; 6(4): 797-806, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23212197

RESUMO

Deficient type I interferon-ß and type III interferon-λ induction by rhinoviruses has previously been reported in mild/moderate atopic asthmatic adults. No studies have yet investigated if this occurs in severe therapy resistant asthma (STRA). Here, we show that compared with non-allergic healthy control children, bronchial epithelial cells cultured ex vivo from severe therapy resistant atopic asthmatic children have profoundly impaired interferon-ß and interferon-λ mRNA and protein in response to rhinovirus (RV) and polyIC stimulation. Severe treatment resistant asthmatics also exhibited increased virus load, which negatively correlated with interferon mRNA levels. Furthermore, uninfected cells from severe therapy resistant asthmatic children showed lower levels of Toll-like receptor-3 mRNA and reduced retinoic acid inducible gene and melanoma differentiation-associated gene 5 mRNA after RV stimulation. These data expand on the original work, suggesting that the innate anti-viral response to RVs is impaired in asthmatic tissues and demonstrate that this is a feature of STRA.


Assuntos
Asma/genética , Asma/imunologia , Hipersensibilidade Imediata/genética , Hipersensibilidade Imediata/imunologia , Imunidade Inata/genética , Interferons/genética , Adolescente , Asma/metabolismo , Criança , Pré-Escolar , Proteína DEAD-box 58 , RNA Helicases DEAD-box/genética , RNA Helicases DEAD-box/metabolismo , Feminino , Regulação da Expressão Gênica , Humanos , Hipersensibilidade Imediata/metabolismo , Imunoglobulina E/imunologia , Helicase IFIH1 Induzida por Interferon , Interferon beta/genética , Interferon gama/genética , Interleucina-8/biossíntese , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/virologia , Masculino , Infecções por Picornaviridae/genética , Infecções por Picornaviridae/imunologia , Poli I-C/administração & dosagem , Poli I-C/imunologia , RNA Mensageiro/genética , Receptores Imunológicos , Mucosa Respiratória/efeitos dos fármacos , Mucosa Respiratória/imunologia , Mucosa Respiratória/metabolismo , Mucosa Respiratória/virologia , Rhinovirus/imunologia , Fatores de Tempo , Receptor 3 Toll-Like/genética , Receptor 3 Toll-Like/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA